FSCN1 and triple-negative breast carcinoma: During our testing of various TNBC cells for their growth sensitivity to fascin inhibitors, we noticed that the growth of MDA-MB-468, BT-20, and HCC38 triple-negative breast cancer cells were sensitive to fascin inhibitors (Figure 6A–D).